• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Polymyxin B sulfate

Polymyxin B sulfate

Product ID P5747
Cas No. 1405-20-5
Purity ≥6500 iu/mg
Product Unit SizeCostQuantityStock
250 mg $71.50 In stock
1 g $168.00 In stock
5 g $729.30 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Polymyxin B is a mixture of polymyxin B1, B2, B3 and B1-1 sulfates; polymyxin B is a cationic lipid oligopeptide derived from Bacillus polymyxa that displays antibacterial activity against all gram-negative bacteria except species of Proteus. Polymyxin B kills both proliferative and quiescent cells in vitro. Polymyxin B inhibits cellular respiration by inhibiting type II NADH-quinone oxidoreductase activity. This compound also induces aggregation of lipopolysaccharide (LPS) in bacterial cell membranes, altering membrane potential and causing leakage of cellular components. Polymyxin B has been used to treat septic shock induced by LPS of gram-negative bacteria, preventing LPS-induced caspase activity, Fas expression, Bax/Bcl-2 ratio alteration, and apoptosis.

Product Info

Cas No.

1405-20-5

Purity

≥6500 iu/mg

Formula

C56H100N16O17S

Formula Wt.

1301.6

IUPAC Name

N-[4-amino-1-[[1-[[4-amino-1-oxo-1-[[6,9, 18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-(2-methylpropyl)- 2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16, 19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1- oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide;sulfuric acid

Synonym

Aerosporin

Solubility

Soluble in water (50 mg/mL, hazy solution).

Appearance

White to off white powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

P5747 MSDS PDF

Info Sheet

P5747 Info Sheet PDF

References

Deris ZZ, Akter J, Sivanesan S, et al. A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity. J Antibiot (Tokyo). 2013 Oct 30. [Epub ahead of print]. PMID: 24169795.

Zhai B, Lin X. Evaluation of the anticryptococcal activity of the antibiotic polymyxin B in vitro and in vivo. Int J Antimicrob Agents. 2013 Mar;41(3):250-4. PMID: 23313397

Domingues MM, Inácio RG, Raimundo JM, et al. Biophysical characterization of polymyxin B interaction with LPS aggregates and membrane model systems. Biopolymers. 2012;98(4):338-44. PMID: 23193598.

Martin EL, Ranieri VM. Endotoxin removal by polymyxin B immobilized cartridge inactivates circulating proapoptotic factors. Contrib Nephrol. 2010;167:65-76. PMID: 20519900.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • B8276

    Butyric Acid Sodium

    HDAC inhibitor, RNA splicing modulator.

    ≥98%
  • A5281

    Angiotensin II (4-8), human

    Endogenous peptide fragment, involved in vasoco...

    ≥95%
  • M1779

    Methyldopa Sesquihydrate

    DOPA decarboxylase inhibitor, indirect α2-adre...

    ≥98%
  • Z3444

    Zileuton

    5-Lipoxygenase inhibitor.

    ≥98%
  • E537331

    Enniatin Complex

    Mycotoxin contaminant found in cereal grains.

    ≥98%
  • M2076

    Metformin Hydrochloride

    AMPK activator.

    ≥98%
  • P0146

    Palmitoyl-L-carnitine

    Long chain acylcarnitine involved in fatty acid...

    ≥98%
  • L0360

    Lapatinib Ditosylate Monohydrate

    EGFR inhibitor.

    ≥99%
  • I7457

    1-Isothiocyanato-6-(methylsulfinyl)-hexane

    Synthetic derivative of 6-methylsulfinyl-hexane...

    ≥98%
  • S8047

    R,S-Sulforaphane, Research Grade

    Synthetic ITC.

    ≥97%
  • T5870

    Torin 1

    Tricyclic benzonaphthyridinone; mTORC1/2 inhibi...

    ≥98%
  • A5134

    Aminophylline Anhydrous

    Adenosine antagonist, PDE inhibitor.

    ≥98%
  • T1006

    10-Acetoacetyl Paclitaxel

    Synthesis impurity

    ≥95%
  • A2244

    Aflatoxicol

    Mycotoxin, metabolite of aflatoxin B1 produced ...

    ≥98%
  • P005095

    N-Debenzoylpaclitaxel

    Paclitaxel derivative

    ≥95%
  • M9608

    Myclobutanil

    14-α demethylase inhibitor.

    ≥97%
  • B022691

    Baricitinib

    Selective and reversible JAK inhibitor.

    ≥99%
  • W3576

    Withaferin A

    Steroid lactone produced by Withania somnifera;...

    ≥98%
  • C0365

    Carvedilol

    FIASMA; α1- and β1/2-adrenergic antagonist.

    ≥98%
  • W0274

    S-(−)-Warfarin Sodium >99%ee

    Coumarin, more potent isomer; VKORC1 inhibitor....

    ≥99%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only